|
1
|
Sakuma M, Nakamura M, Yamada N, Ota S,
Shirato K, Nakano T, Ito M and Kobayashi T: Venous thromboembolism:
Deep vein thrombosis with pulmonary embolism, deep vein thrombosis
alone and pulmonary embolism alone. Circ J. 73:305–309. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang KL, Yap ES, Goto S, Zhang S, Siu CW
and Chiang CE: The diagnosis and treatment of venous
thromboembolism in asian patients. Thromb J. 16:42018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hattab Y, Küng S, Fasanya A, Ma K, Singh
AC and DuMont T: Deep venous thrombosis of the upper and lower
extremity. Crit Care Nurs Q. 40:230–236. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hollenhorst MA and Battinelli EM:
Thrombosis, Hypercoagulable states and anticoagulants. Prim Care.
43:619–635. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Xia H, Wang Y, Chen L, Li S,
Hussein IA, Wu Y, Shang Y, Yao S and Du R: The rate of missed
diagnosis of lower-limb DVT by ultrasound amounts to 50% or so in
patients without symptoms of DVT: A meta-analysis. Medicine
(Baltimore). 98:e171032019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rabinovich A and Kahn SR: The
postthrombotic syndrome: Current evidence and future challenges. J
Thromb Haemost. 15:230–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Heit JA, Spencer FA and White RH: The
epidemiology of venous thromboembolism. J Thromb Thrombolysis.
41:3–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kahn SR: The post-thrombotic syndrome.
Hematology Am Soc Hematol Educ Program. 2016:413–418. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stain M, Schonauer V, Minar E, Bialonczyk
C, Hirschl M, Weltermann A, Kyrle PA and Eichinger S: The
post-thrombotic syndrome: Risk factors and impact on the course of
thrombotic disease. J Thromb Haemost. 3:2671–2676. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robert-Ebadi H and Righini M: Management
of distal deep vein thrombosis. Thromb Res. 149:48–55. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olaf M and Cooney R: Deep venous
thrombosis. Emerg Med Clin North Am. 35:743–770. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mammen EF: Pathogenesis of venous
thrombosis. Chest. 102 (Suppl):640S–644S. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kirwan CC, McCollum CN, McDowell G and
Byrne GJ: Investigation of proposed mechanisms of
chemotherapy-induced venous thromboembolism: Endothelial cell
activation and procoagulant release due to apoptosis. Clin Appl
Thromb Hemost. 21:420–427. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Wang J, Wang B, Yang J, Gong Z,
Zhao X, Zhang C and Du K: MiR-126 inhibits vascular endothelial
cell apoptosis through targeting PI3K/Akt signaling. Ann Hematol.
95:365–374. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shyy JY and Chien S: Role of integrins in
endothelial mechanosensing of shear stress. Circ Res. 91:769–775.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bombeli T, Karsan A, Tait JF and Harlan
JM: Apoptotic vascular endothelial cells become procoagulant.
Blood. 89:2429–2442. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mo J, Huang H, He F, et al: Influence of
apoptosis signal pathway in traumatic deep vein thrombosis. J
Kunming Med Univ. 28:5–7. 2007.
|
|
18
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Soifer HS, Rossi JJ and Saetrom P:
MicroRNAs in disease and potential therapeutic applications. Mol
Ther. 15:2070–2079. 2017. View Article : Google Scholar
|
|
21
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Connell RM, Rao DS, Chaudhuri AA and
Baltimore D: Physiological and pathological roles for microRNAs in
the immune system. Nat Rev Immunol. 10:111–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ten Cate H: MicroRNA and venous
thrombosis. Thromb Haemost. 116:2052016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang X, Sundquist K, Elf JL, Strandberg K,
Svensson PJ, Hedelius A, Palmer K, Memon AA, Sundquist J and Zöller
B: Diagnostic potential of plasma microRNA signatures in patients
with deep-vein thrombosis. Thromb Haemost. 116:328–336. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Zhu X, Du X, Xu A, Yuan X, Zhan Y,
Liu M and Wang S: MiR-150 promotes angiogensis and proliferation of
endothelial progenitor cells in deep venous thrombosis by targeting
SRCIN1. Microvasc Res. 123:35–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong L, Hu N, Du X, Wang W, Chen H, Li W,
Wei S, Zhuang H, Li X and Li C: Upregulation of miR-483-3p
contributes to endothelial progenitor cells dysfunction in deepvein
thrombosis patients via SRF. J Transl Med. 14:232016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qin J, Liang H, Shi D, Dai J, Xu Z, Chen
D, Chen X and Jiang Q: A panel of microRNAs as a new biomarkers for
the detection of deep vein thrombosis. J Thromb Thrombolysis.
39:215–221. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang R, Xing L, Zheng X, Sun Y, Wang X and
Chen J: The circRNA circAGFG1 acts as a sponge of miR-195-5p to
promote triple-negative breast cancer progression through
regulating CCNE1 expression. Mol Cancer. 18:42019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng J, Xu T, Chen F and Zhang Y:
MiRNA-195-5p functions as a tumor suppressor and a predictive of
poor prognosis in non-small cell lung cancer by directly targeting
CIAPIN1. Pathol Oncol Res. 25:1181–1190. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li M, Ren CX, Zhang JM, Xin XY, Hua T and
Wang HB and Wang HB: The Effects of miR-195-5p/MMP14 on
proliferation and invasion of cervical carcinoma cells through TNF
signaling pathway based on bioinformatics analysis of microarray
profiling. Cell Physiol Biochem. 50:1398–1413. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kong F, Ma J, Yang H, Yang D, Wang C and
Ma X: Long non-coding RNA PVT1 promotes malignancy in human
endometrial carcinoma cells through negative regulation of
miR-195-5p. Biochim Biophys Acta Mol Cell Res. Jul 19–2018.doi:
10.1016/j.bbamcr.2018.07.008 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhu N, Huang K, Liu Y, Zhang H, Lin E,
Zeng Y, Li H, Xu Y, Cai B, Yuan Y, et al: miR-195-5p regulates hair
follicle inductivity of dermal papilla cells by suppressing
Wnt/β-catenin activation. Biomed Res Int. 2018:49243562018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou G, Zhang X, Wang W, Zhang W, Wang H
and Xin G: Both peripheral blood and urinary miR-195-5p,
miR-192-3p, miR-328-5p and their target genes PPM1A, RAB1A and
BRSK1 may be potential biomarkers for membranous nephropathy. Med
Sci Monit. 25:1903–1916. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zeng Z, Yao J, Li Y, Xue Y, Zou Y, Shu Z
and Jiao Z: Anti-apoptosis endothelial cell-secreted
microRNA-195-5p promotes pulmonary arterial smooth muscle cell
proliferation and migration in pulmonary arterial hypertension. J
Cell Biochem. 119:2144–2155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sandrim VC, Dias MC, Bovolato AL,
Tanus-Santos JE, Deffune E and Cavalli RC: Plasma from
pre-eclamptic patients induces the expression of the
anti-angiogenic miR-195-5p in endothelial cells. J Cell Mol Med.
20:1198–1200. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Latronico MV, Catalucci D and Condorelli
G: Emerging role of microRNAs in cardiovascular biology. Circ Res.
101:1225–1236. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hirata H, Lopes GS, Jurkiewicz A,
Garcez-do-Carmo L and Smaili SS: Bcl-2 modulates endoplasmic
reticulum and mitochondrial calcium stores in PC12 cells. Neurochem
Res. 37:238–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Naz R, Naz S, Mehboob M, Achakzai A and
Khalid GH: Diagnostic yield of color Doppler ultrasonography in
deep vein thrombosis. J Coll Physicians Surg Pak. 15:276–279.
2005.PubMed/NCBI
|
|
39
|
Bates SM, Jaeschke R, Stevens SM, Goodacre
S, Wells PS, Stevenson MD, Kearon C, Schunemann HJ, Crowther M,
Pauker SG, et al: Diagnosis of DVT: Antithrombotic therapy and
prevention of thrombosis, 9th ed: American college of chest
physicians evidence-based clinical practice guidelines. Chest. 141
(2 Suppl):e351S–e418S. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang H, Meng Z, Zhang C, Zhang P and Wang
Q: Establishing a new rat model of central venous sinus thrombosis
and analyzing its pathophysiological and apoptotic changes. J
Neurosci Methods. 203:130–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cordes KR and Srivastava D: MicroRNA
regulation of cardiovascular development. Circ Res. 104:724–732.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jin Y, Wang M, Hu H, Huang Q, Chen Y and
Wang G: Overcoming stemness and chemoresistance in colorectal
cancer through miR-195-5p-modulated inhibition of notch signaling.
Int J Biol Macromol. 117:445–453. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chai L, Kang XJ, Sun ZZ, Zeng MF, Yu SR,
Ding Y, Liang JQ, Li TT and Zhao J: MiR-497-5p, miR-195-5p and
miR-455-3p function as tumor suppressors by targeting hTERT in
melanoma A375 cells. Cancer Manag Res. 10:989–1003. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang C, Wu K, Wang S and Wei G: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
YAP via miR-195-5p. J Cell Biochem. 119:5646–5656. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cai C, He H, Duan X, Wu W, Mai Z, Zhang T,
Fan J, Deng T, Zhong W, Liu Y, et al: miR-195 inhibits cell
proliferation and angiogenesis in human prostate cancer by
downregulating PRR11 expression. Oncol Rep. 39:1658–1670.
2018.PubMed/NCBI
|
